Cardiovascular disease—including heart attack, stroke, and heart failure—is a leading cause of death and disability worldwide. In 2019, CVDs accounted for 17.9 million deaths and a major share of premature mortality before age 70. The burden is especially heavy in low- and middle-income countries and is shaped by risk factors such as smoking and high body-mass index. This page also covers prevention and treatment approaches, from blood pressure control to statins and newer therapies.
Key Takeaways
- Global CVD economic cost is $1 trillion yearly in health and productivity loss
- US spends $363 billion annually on CVD care
- Heart disease costs US $219 billion yearly including lost productivity
- In 2019, cardiovascular diseases (CVDs) caused 17.9 million deaths worldwide, equivalent to 32% of all global deaths
- Globally, 38% of premature deaths due to CVDs occur before the age of 70
- Of the 17.9 million CVD deaths in 2019, 85% were due to heart attack and stroke
- Global DALYs from CVD reached 520 million in 2019
- Nearly 523 million people worldwide were living with CVD in 2019
- Heart failure prevalence is 1-2% in general adult population, rising to 10% over age 70
- In women, 44% of CVD burden is attributable to behavioral risks
- Smoking causes 1.74 million CVD deaths yearly worldwide
- High body-mass index led to 5 million CVD deaths in 2019
- Statins reduce CVD events by 25% per 1 mmol/L LDL reduction
- Aspirin reduces CVD mortality by 23% in secondary prevention
- Blood pressure lowering reduces stroke risk by 35-40%
CVD kills 17.9 million people yearly and costs $1 trillion, but treatments like blood pressure control and statins can cut risks.
Related reading
01 · Category
Economic15 stats
01
Global CVD economic cost is $1 trillion yearly in health and productivity loss
02
US spends $363 billion annually on CVD care
03
Heart disease costs US $219 billion yearly including lost productivity
04
Stroke costs US $56 billion in direct medical costs 2020
05
In EU, CVD costs €210 billion yearly, 51% healthcare
06
China CVD costs $128 billion in 2019
07
India faces $2.5 trillion cumulative CVD cost 2010-2050
08
Low/middle-income countries lose $3.7 trillion GDP to CVD 2011-2025
09
UK CVD costs £19 billion yearly to economy
10
Australia spends $14.2 billion on CVD in 2020-21
11
Brazil CVD healthcare cost $5.7 billion yearly
12
Canada CVD costs $22 billion annually
13
South Africa loses 1.5% GDP to CVD
14
Global productivity loss from CVD is $470 billion yearly
15
US Medicare spends 25% of budget on CVD
Interpretation
Economic Interpretation
From an economic angle, cardiovascular disease is already costing the world at enormous scale, with global losses reaching about $1 trillion each year and major regional burdens like the US at $363 billion annually and the EU at €210 billion, showing CVD is a persistent drag on health systems and productivity far beyond any single country.
02 · Category
Mortality30 stats
01
In 2019, cardiovascular diseases (CVDs) caused 17.9 million deaths worldwide, equivalent to 32% of all global deaths
02
Globally, 38% of premature deaths due to CVDs occur before the age of 70
03
Of the 17.9 million CVD deaths in 2019, 85% were due to heart attack and stroke
04
Over three-quarters of CVD deaths take place in low- and middle-income countries
05
In 2019, 160 million people were living with heart failure globally
06
Age-standardized CVD mortality rate declined by 28.2% globally from 2000 to 2019
07
In 2019, ischemic heart disease caused 8.9 million deaths worldwide
08
Stroke accounted for 6.6 million deaths globally in 2019
09
CVD death rates are 1.5 times higher in rural areas than urban areas in the US
10
In the US, heart disease is the leading cause of death, killing nearly 700,000 people in 2021
11
Stroke kills about 160,000 Americans annually
12
Black Americans have the highest death rate from heart disease at 211.6 per 100,000
13
In Europe, CVD causes over 4 million deaths yearly, representing 45% of all deaths
14
Age-standardized mortality rate from CVD in EU was 172.3 per 100,000 in 2019
15
In low-income countries, 37.5% of CVD deaths occur under age 70
16
High systolic blood pressure accounted for 10.8 million CVD deaths in 2019
17
In 2020, COVID-19 increased CVD mortality by 10-15% in high-income countries
18
Global CVD mortality projected to rise to 23.6 million by 2030
19
In India, CVD causes 2.8 million deaths annually, 25% of all deaths
20
China sees 4.5 million CVD deaths per year
21
In sub-Saharan Africa, rheumatic heart disease mortality is 0.15 million yearly
22
US men have a CVD mortality rate of 179.8 per 100,000 vs 126.1 for women
23
In the UK, CVD mortality fell 76% from 1979 to 2019
24
Australia reports 47,000 CVD deaths in 2020
25
Japan has the lowest CVD mortality at 110 per 100,000
26
Russia has high CVD mortality at 500 per 100,000
27
In Brazil, CVD causes 400,000 deaths yearly
28
Canada sees 55,000 CVD deaths annually
29
In South Africa, CVD mortality rate is 250 per 100,000
30
28.2% decline in global age-standardized CVD mortality from 2000 to 2019
Interpretation
Mortality Interpretation
From a mortality perspective, cardiovascular diseases accounted for 17.9 million deaths in 2019 and although the age standardized CVD mortality rate fell 28.2% since 2000, most of the burden still falls on low and middle income countries with 38% of premature deaths occurring before age 70.
report visual · Highlight
Global CVD mortality decline (2000–2019)
Between 2000 and 2019, global age-standardized CVD mortality declined, with the reported overall decrease led by the same magnitude across the available global index views (about a
-28.2%
28.2% decline in global age-standardized CVD mortality from 2000 to 2019
source-verifiedvizhub.healthdata.org2000
03 · Category
Prevalence25 stats
01
Global DALYs from CVD reached 520 million in 2019
02
Nearly 523 million people worldwide were living with CVD in 2019
03
Heart failure prevalence is 1-2% in general adult population, rising to 10% over age 70
04
Atrial fibrillation prevalence is 2-3% in people over 65
05
Globally, hypertension affects 1.28 billion adults aged 30-79
06
In the US, 127.9 million adults have CVD
07
About 48% of US adults have some form of CVD
08
Coronary heart disease affects 20.1 million US adults
09
Heart failure prevalence in US is 6.7 million people age 20+
10
Stroke prevalence in US adults is 3%, or 7.4 million people
11
In Europe, 49 million people live with CVD
12
Hypertension prevalence in EU is 30-45% of adults
13
In China, 330 million people have CVD
14
India has 75 million hypertension cases
15
In low-income countries, CVD prevalence is rising 2% annually
16
Australia has 1.2 million with coronary heart disease
17
UK prevalence of CVD is 7.6% in adults
18
In Brazil, 35 million adults have hypertension
19
Canada reports 2.6 million with heart disease
20
South Africa has 7.5 million hypertensives
21
Japan has 15 million CVD patients
22
Russia sees 20 million with hypertension
23
In sub-Saharan Africa, 100 million have hypertension
24
Global atrial fibrillation cases numbered 59 million in 2019
25
US peripheral artery disease affects 8.5 million adults
Interpretation
Prevalence Interpretation
In 2019, cardiovascular disease was already widespread, with nearly 523 million people living with it worldwide and 1.28 billion adults aged 30 to 79 affected by hypertension, showing how prevalent CVD remains across populations and ages.
More related reading
04 · Category
Risk Factors25 stats
01
In women, 44% of CVD burden is attributable to behavioral risks
02
Smoking causes 1.74 million CVD deaths yearly worldwide
03
High body-mass index led to 5 million CVD deaths in 2019
04
Ambient particulate matter pollution causes 1.1 million CVD deaths annually
05
Hypertension is the leading modifiable risk factor, causing 29% of CVD deaths
06
Diabetes prevalence increases CVD risk by 2-4 fold
07
In US, 47% of adults have high blood pressure
08
Obesity affects 42% of US adults, doubling CVD risk
09
Smoking is responsible for 20% of CVD deaths in US
10
Physical inactivity contributes to 6% of global CVD burden
11
High LDL cholesterol raises CVD risk by 25-30%
12
In Europe, 26% of adults smoke, major CVD risk
13
Air pollution PM2.5 increases CVD risk by 10-20%
14
Poor diet causes 11 million CVD deaths yearly
15
Family history doubles CVD risk if first-degree relative affected before 60
16
Chronic kidney disease triples CVD risk
17
In women, oral contraceptives increase stroke risk 2-fold if hypertensive
18
HIV infection raises CVD risk by 50-100%
19
Socioeconomic disadvantage increases CVD risk by 40%
20
Shift work elevates CVD risk by 40%
21
High sodium intake causes 1.89 million CVD deaths yearly
22
Low fruit intake responsible for 2.5 million CVD deaths
23
In US Blacks, hypertension prevalence is 56% vs 48% Whites
24
Alcohol consumption >14 drinks/week raises CVD risk 20%
25
Depression increases CVD risk by 30-50%
Interpretation
Risk Factors Interpretation
For the risk factors driving CVD, hypertension is the standout modifiable culprit accounting for 29% of CVD deaths, and together with major behavioral and environmental hazards like smoking at 1.74 million deaths yearly and ambient particulate pollution at 1.1 million, these inputs underscore how preventable risks are fueling millions of deaths each year.
05 · Category
Treatment21 stats
01
Statins reduce CVD events by 25% per 1 mmol/L LDL reduction
02
Aspirin reduces CVD mortality by 23% in secondary prevention
03
Blood pressure lowering reduces stroke risk by 35-40%
04
SGLT2 inhibitors reduce heart failure hospitalization by 30%
05
Cardiac rehab reduces CVD mortality by 20-30%
06
In US, 90% of eligible get statins for secondary prevention
07
ICD implantation reduces sudden death by 30% in high-risk patients
08
PCI success rate for STEMI is 95%, reducing mortality to 5%
09
CABG improves survival by 20% over PCI in multivessel disease
10
Anticoagulation for AF reduces stroke by 64%
11
Lifestyle intervention reduces CVD events by 30% in diabetes
12
GLP-1 agonists cut major CVD events by 12-26%
13
Smoking cessation reduces CVD risk by 50% within 1 year
14
Mediterranean diet lowers CVD recurrence by 30%
15
In Europe, BP control rates are 40% in hypertensives
16
Beta-blockers post-MI reduce mortality by 23%
17
TAVR success rate is 95% for aortic stenosis
18
Renal denervation lowers BP by 10 mmHg in resistant HTN
19
Exercise training improves ejection fraction by 3-4% in HF
20
DOACs have 50% lower intracranial bleed risk vs warfarin
21
Colchicine reduces CVD events by 31% post-ACS
Interpretation
Treatment Interpretation
In the treatment category, multiple interventions show consistent benefit at the patient-outcome level, such as statins cutting CVD events by about 25% per 1 mmol/L LDL reduction and blood pressure lowering reducing stroke risk by 35 to 40%.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Emilia Santos. (2026, February 13). Cvd Statistics. Gitnux. https://gitnux.org/cvd-statistics
MLA
Emilia Santos. "Cvd Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/cvd-statistics.
Chicago
Emilia Santos. 2026. "Cvd Statistics." Gitnux. https://gitnux.org/cvd-statistics.
Sources & references
1 datasets cited across this report · attribution is report-level